U.S. Oil and Gas Stock News

Why Dime Community Bancshares is back on investor radars Dime Community Bancshares (DCOM) just posted full year 2025 results, reporting net interest income of US$408 million and net income of US$110.68 million, alongside lower quarterly net loan charge offs compared with last year. See our latest analysis for Dime Community Bancshares. The latest full year figures and improvement in net loan charge offs have arrived after a mixed stretch for the stock, with a 1 day share price return of 2.56%...

Precigen, Inc. recently announced that an expert consensus paper in The Laryngoscope, sponsored by the Recurrent Respiratory Papillomatosis Foundation and authored by 16 leading physicians, recommends PAPZIMEOS (zopapogene imadenovec) as the new first-line standard of care for adults with recurrent respiratory papillomatosis. This independently authored guidance marks a pivotal shift away from repeated surgical procedures toward an FDA-approved HPV-specific immunotherapy that targets the...

Quanta Services (PWR) is back in focus after new grid modernization and energy transition contracts helped push its project backlog to a record level, just as investors look ahead to the upcoming Q4 2025 earnings release. See our latest analysis for Quanta Services. The recent contract wins, record backlog and expectations for the upcoming Q4 2025 results come on top of a multi month rally, with a 30 day share price return of 8.63% and a 1 year total shareholder return of 29.61%. This...

Zions Bancorporation, National Association reported past fourth-quarter 2025 earnings with net interest income of US$683 million and net income of US$263 million, lifting diluted EPS from continuing operations to US$1.76 versus US$1.34 a year earlier. For 2025 as a whole, the bank’s net income rose to US$899 million and diluted EPS to US$6.01, alongside expanding net interest margin, strong deposit growth, and stable credit quality that collectively strengthened its capital position. We’ll...

Perella Weinberg Partners (PWP) is in focus after announcing a board leadership transition, with founder Peter A. Weinberg set to step down as Chairman and CEO Andrew Bednar preparing to assume the Chairman role. See our latest analysis for Perella Weinberg Partners. The leadership transition news comes as Perella Weinberg Partners’ share price has moved to US$21.60, with a 30 day share price return of 24.14% and a 3 year total shareholder return of 129.20%. This suggests longer term...

Corvus Pharmaceuticals recently reported positive results from cohort 4 of its randomized, blinded, placebo-controlled Phase 1 trial of oral soquelitinib in moderate to severe atopic dermatitis, and confirmed plans to start a Phase 2 study in the first quarter of 2026. The cohort 4 data are particularly interesting because they show clinical activity in patients who had previously failed systemic treatments, including dupilumab and JAK inhibitors, while maintaining a favorable safety profile...

In November 2025, uniQure disclosed that the FDA found data from its Phase I/II AMT-130 Huntington’s disease studies insufficient to support a Biologics License Application, and later feedback questioned the adequacy of its external-control dataset for accelerated approval. This setback highlights how emerging regulatory expectations around evidence standards can materially affect the development path of gene therapies even when early efficacy signals appear encouraging. We’ll now examine...

In recent months, Packaging Corporation of America has benefited from growing optimism about a recovery in the packaging cycle, supported by disciplined containerboard pricing and management’s focus on high-return mill investments. What stands out is the company’s decision to emphasize cost efficiency and cash returns to shareholders instead of pursuing large acquisitions, signaling a measured approach to capital allocation. Next, we’ll examine how this emphasis on disciplined pricing...

Entergy (ETR) is back in focus after several Wall Street firms reiterated or upgraded their views, pointing to expectations for sustained EPS growth supported by industrial and data center demand and constructive regulation. See our latest analysis for Entergy. At a share price of US$94.75, Entergy’s recent 30 day share price return of 3.55% contrasts with a softer 90 day share price return of a 1.30% decline. A 1 year total shareholder return of 16.51% sits alongside very strong 3 and 5 year...

What Sun Communities’ recent performance might be telling investors Sun Communities (SUI) has drawn attention after a recent move that left its shares around $125.99, with total return over the past year at about 5%, and roughly flat performance over the past 3 years. See our latest analysis for Sun Communities. The recent 1 day share price decline of about 3.3% comes after a 30 day share price return of 2.7% and a 1 year total shareholder return of roughly 5%, suggesting only modest momentum...

Service Corporation International (SCI) has been in focus after its latest quarter showed 4.4% year on year revenue growth, topping analyst expectations by 1.5%, while recent positive Wall Street coverage has added another layer of investor attention. See our latest analysis for Service Corporation International. The share price, which closed at $82.35, has had a 5.3% 30 day share price return and a 6.7% year to date share price return. The 5 year total shareholder return of 66.1% points to...

West Pharmaceutical Services recently announced at Pharmapack 2026 in Paris the global commercial availability of its West Synchrony S1 prefillable syringe system, offering multiple configurations tailored for biologics and vaccines. An interesting angle is how Synchrony S1 expands West’s presence in integrated drug-device delivery solutions at a time of rising combination-product demand. Next, we’ll examine how this Synchrony S1 launch shapes West’s broader investment narrative around...

Disc Medicine recently faced a two-week postponement of the U.S. FDA’s review of its rare disease candidate bitopertin, as regulators raised questions about efficacy endpoints, data integrity, and potential abuse risk. At the same time, the company appointed industry veteran Lisa Amaya Price as Chief Human Resources Officer, signaling an effort to strengthen its organizational backbone as it prepares for possible commercialization. Next, we’ll examine how the FDA’s temporary review delay for...

Reverse split reshapes Ozop Energy Solutions share structure Ozop Energy Solutions (OZSC) is carrying out a 1 for 5,000 reverse stock split effective January 21, 2026. This move sharply consolidates its share count and changes the trading price per share. This type of corporate action does not alter the company’s reported revenue of US$0.32 million or its loss of US$6.95 million, but it can influence liquidity, trading behavior, and how different investors view the stock. See our latest...

Some investors may be wondering whether Workday is starting to look interesting at its current price, or whether the shares still carry a premium that is hard to justify. After closing at US$182.99, the stock has seen a 16.3% decline over the last 30 days and a 27.0% decline over the last year. These moves may have changed how some investors think about its growth potential and risk. Recent coverage has focused on Workday's position in enterprise software and its ongoing push to win and...

InterDigital, Inc. recently issued full-year 2026 guidance, projecting revenue between US$675,000,000 and US$775,000,000 and diluted EPS of US$5.77 to US$8.51. The company also announced a new patent license agreement with LG Electronics covering digital TVs and computer monitors, broadening monetization of its ATSC 3.0, Wi‑Fi, and video codec technologies through a joint licensing program with Sony. We’ll examine how the LG Electronics licensing deal, alongside the new 2026 guidance, shapes...

Pinnacle Financial Partners, a regional banking company, recently reported its latest quarterly results after a period of analyst expectations for double‑digit year‑on‑year revenue growth and a history of outperforming forecasts. Analysts had largely reaffirmed their estimates ahead of the release, highlighting how the bank’s consistent revenue outperformance has become a key focus for investors. With a recent 7-day gain and attention on its history of beating revenue forecasts, we will...

Enphase Energy (NasdaqGM:ENPH) has launched the IQ9N-3P, its first U.S.-manufactured, gallium nitride based commercial microinverter. The product is designed for the commercial solar market and is built to meet domestic content requirements and FEOC compliance standards. The IQ9N-3P targets grid safety, installation efficiency, and scalable deployment for U.S. commercial solar projects. Enphase Energy focuses on microinverters and related energy management technology for solar and storage...

If you are wondering whether Intercontinental Exchange stock still offers value at today's levels, it helps to step back and look at what the current price is actually implying. The shares last closed at US$170.95, with returns of 2.6% over the past week, 6.6% over the past month, 6.9% year to date, 14.0% over 1 year, 67.3% over 3 years, and 61.8% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent news coverage has focused on...

Omega Healthcare Investors (NYSE:OHI) is showing a strong technical breakout pattern, pointing to renewed investor interest in the healthcare REIT space. The breakout aligns with a confirmed uptrend and a solid technical setup that traders may use as a rule-based entry signal. With shares last closing at $45.04, the move is drawing fresh attention from investors watching healthcare focused real estate names. For context, Omega Healthcare Investors has delivered a 28.1% return over the past...

Recent performance snapshot EMCOR Group (EME) has drawn investor attention after recent trading, with the stock last closing at $687.76. The shares show a 1 day return of 1.56% and a 7 day gain of 2.57%. Over the past month, the stock shows a 12.49% return, compared with a 3.75% gain in the past 3 months. Year to date, the return stands at 7.69%, while the 1 year total return is 30.74%. See our latest analysis for EMCOR Group. EMCOR Group’s recent share price pullback, with a 1 day share...

A. O. Smith Corporation recently declared a regular quarterly cash dividend of US$0.36 per share, payable on February 17, 2026, to shareholders of record as of January 30, 2026, while also pursuing a US$470 million acquisition of Leonard Valve. This combination of maintaining its dividend and expanding through acquisition comes as the company narrows its outlook due to ongoing pressures in the Chinese market. We’ll now examine how the maintained dividend amid Chinese market headwinds shapes...

In recent months, Danaher has reported mixed quarterly results and guidance, while also outlining expectations for mid‑single‑digit sales growth and adjusted diluted EPS in 2025 during past investor updates. At the same time, the company’s core business has faced pressure, with organic revenue, operating margins and free cash flow margins all moving lower over multi‑year periods, prompting debate about the quality of its underlying performance. We’ll now examine how these pressures on...

If you are wondering whether Abbott Laboratories at around US$121 a share is offering fair value or a potential mispricing, you are in the right place. The stock is modestly positive over 1 year with a 5.7% return, but has seen shorter term pullbacks with a 2.5% decline over 7 days and a 3.4% decline over 30 days, while the 3 and 5 year figures sit at 14.2% and 15.7% respectively. Recent headlines around Abbott Laboratories have focused on its position in medical devices and diagnostics, as...